CVRx vs Stereotaxis
CVRX and STXS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVRX and STXS compare
Stereotaxis is the larger company, worth 5.4 times as much as CVRx ($88.4M against $16.3M).
CVRx grew revenue faster over the last twelve months (12.0% versus −5.5% for Stereotaxis).
Stereotaxis keeps more of each dollar of sales as profit, with a net margin of −74.2% compared with −84.9% at CVRx.
CVRx scores higher on the StockData Score (8 against 7 for Stereotaxis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVRX | STXS |
|---|---|---|
| Size and price | ||
| Market cap | $16.3M | $88.4M |
| Share price | $0.611 | $0.882 |
| Change, 1 year | −93.4% | −60.3% |
| Change, 5 years | −95.3% | −85.2% |
| Beta (5Y) | −0.96 | 1.00 |
| Employees | 223 | 131 |
| StockData Score | ||
| Total score | 8 (better) | 7 |
| Valuation score | 3 (better) | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× (better) | 2.9× |
| P/B | 0.8× (better) | 7.2× |
| FCF yield | −252% | −17.5% (better) |
| Fair value | $7.11 | $1.08 |
| Margin of safety | 91.4% (better) | 18.0% |
| Growth | ||
| Revenue growth (TTM) | 12.0% (better) | −5.5% |
| Revenue growth, 5Y average | 56.4% (better) | 4.0% |
| Profitability | ||
| Gross margin | 86.9% (better) | 55.6% |
| Operating margin | −79.5% | −75.7% (better) |
| Net margin | −84.9% | −74.2% (better) |
| FCF margin | −67.1% | −51.6% (better) |
| Return on equity | −133% (better) | −326% |
| Return on invested capital | −293% | – |
| Financial health | ||
| Debt / equity | 2.94 (better) | 0.00 |
| Interest coverage | −8.1× | – |
| Current ratio | 8.04 (better) | 1.42 |
| Altman Z-score | −9.29 (better) | −14.13 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | −2.9% (better) | −24.0% |
| Shareholder yield | −2.9% (better) | −24.0% |
| Ownership | ||
| Held by institutions | 57.4% | 43.0% |
| Held by insiders | 49.9% | 20.3% |
| Insider net buying, 12 months | $247K (better) | $0 |
| Short interest, % of float | 13.6% | 7.0% |
Go deeper
- CVRX stock overview
- CVRX income statement
- CVRX valuation and score
- STXS stock overview
- STXS income statement
- STXS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.